Clinical Trial Update: Study of DM-101PX in Adults With Birch Pollen Allergy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for DM-101PX in adults with birch pollen allergy; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• DM-101PX

Snippet

Sponsor: Desentum Oy | Conditions: Birch Pollen Allergy | Phase 2 | Status: ACTIVE_NOT_RECRUITING